JP2017104342A - Volatilization container - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a volatilization container capable of suppressing liquid drip of a volatile medicament.SOLUTION: A volatilization container (1) can store a container body (10) containing a volatile medicament therein in a housing (2, 3). The container body (10) comprises: an opening (120A); a medicament permeable inner lid (122) for covering the opening (120A) and fastened to the container body (10); and a medicament impermeable outer lid (124) for covering the inner lid (122) and adhered to the container body (10) in a peelable state. The housing (2, 3) comprises a vent hole (32), a storage chamber (20) for storing the container body (10), and a liquid absorptive member (7, 8, 9) which contacts the outer lid (124) or positioned in the vicinity of the outer lid (124) when the container body (10) is stored.SELECTED DRAWING: Figure 8

Description

  The present invention relates to a volatilization container capable of housing a container body containing a volatile drug in a housing.

  A fragrance containing a container body containing a fragrance liquid in a thin rectangular casing is known (Patent Document 1). The opening of the container body is covered with a transmission film that transmits the vaporized fragrance. On the permeable film, an impermeable film for preventing the permeation of the vaporized fragrance is laminated, and the diffusion of the fragrance before use is prevented. The container body is accommodated in the casing of the fragrance, and when used, the impervious film of the container body is peeled to expose the permeable film, so that the evaporated fragrance can be removed from the fragrance through the permeable film. To spread.

JP 2010-126204 A

  However, in such a container body, before the use of the fragrance (before the impermeable film is peeled off), the fragrance liquid has permeated the permeable film, resulting in a bonding force at the interface between the permeable film and the impermeable film. It has been found that a weakened gap occurs and the permeated aromatic liquid may accumulate as a liquid in the gap between the permeable film and the impermeable film. In such a state, when the impermeable film is peeled off and the use of the fragrance is started, the fragrance liquid collected in the gap between the permeable film and the impermeable film passes through the container body and the casing to the outside of the fragrance. Dripping down.

  In addition, even when the fragrance is used (after the impermeable film is peeled off), if the volume of the container body decreases due to high temperature environment or impact, etc., and the internal pressure of the container body increases, the fragrance liquid becomes a liquid on the permeable film. It has also been found that it may ooze out. Even in such a state, the container body or the casing may be connected to the fragrance before dripping off the scented fragrant liquid, and the fragrance may spill outside.

  This invention is made | formed in view of the above background, and it aims at providing the volatilization container which suppresses dripping of a volatile chemical | medical agent.

  In order to solve the above-mentioned problem, according to a preferred aspect of the present invention, a volatilization container capable of housing a container body containing a volatile drug in a housing, the container body including an opening, A medicine-permeable inner lid that covers the opening and is fixed to the container body; and a medicine-impermeable outer lid that covers the inner lid and is detachably bonded to the container body, A volatilization container comprising: a vent hole; a storage chamber for storing the container body; and a liquid-absorbing member that contacts the outer lid or is positioned in the vicinity of the outer lid when the container body is stored. To do.

  The drug volatilized from the container body permeates the drug-permeable inner lid that covers the opening of the container body, but does not permeate the impermeable outer lid that covers the inner lid. That is, before the outer lid is peeled off, the volatile drug is not volatilized outside the container body and is released to the outside of the container body when the outer lid is peeled from the container body. Since the volatilization container has a storage chamber that can store the container body and a vent hole, when the container body is stored in the storage chamber and the outer lid of the container body is peeled off, it is released to the outside of the container body. The drug is volatilized into the surrounding environment by touching outside air through the vent.

Here, in a state before the outer lid is peeled off, as a result of the perfume liquid permeating the permeable film, the bonding force between the inner lid and the outer lid of the container body is weakened, and a gap is formed. May accumulate as a liquid. When the outer lid of the container body stored in the storage chamber is peeled in this state, the medicine accumulated in the gap hangs down from the container body. In addition, even after the outer lid is peeled off, the aromatic liquid may ooze out as a liquid on the permeable film when the volume of the container body decreases due to a high temperature environment, impact, or the like and the internal pressure increases. Even in such a state, the container body and the casing are connected to the fragrance and dripped down before the exuded fragrant liquid is volatilized.
In this regard, according to the above configuration, the liquid absorbing member abuts on the outer lid or is positioned in the vicinity when the container body is accommodated, so that even if the drug drops from the container body, the liquid absorbing member It can be absorbed by the member. Thereby, the dripping of the chemical | medical agent to the exterior of a volatilization container can be suppressed. Moreover, since the absorbed medicine is gradually volatilized from the liquid-absorbing member, the medicine can be used without waste.

  If the gap between the inner lid and the outer lid of the container body is caused by poor adhesion between the inner lid and the outer lid at the time of manufacture, the adhesion between the inner lid and the outer lid over time or due to deformation of the container body, etc. There are various possibilities, for example, when the adhesive is weakened, the adhesion between the inner lid and the outer lid is weakened by the drug impregnated in the inner lid, or when it is provided from the beginning by design.

  The liquid-absorbing member may be sheet-like paper or non-woven fabric.

  According to the above configuration, since the liquid-absorbing member is paper or non-woven fabric, the liquid-absorbing property of the drug is high, and dripping can be further suppressed. Moreover, since the shape is sheet-like and the absorbed medicine spreads in the surface direction, the absorbed medicine can be efficiently volatilized in the surrounding environment.

  The housing is configured by fitting a front case having the accommodation chamber and a rear case having the vent hole, and the rear case is directed from the inner surface of the rear case toward the accommodation chamber. A protrusion that defines a gap between the container body and the rear case by contacting the outer lid of the container body when the container body is accommodated, and the liquid-absorbing member includes: It may be arranged in the gap.

  According to the above configuration, since the gap is formed between the rear case and the container body when the container body is accommodated, the medicine does not adhere to the entire inner surface of the rear case even if the medicine drips out. The drug can be absorbed by the liquid-absorbing member disposed in the gap. In addition, since a gap is formed between the rear case and the container body when the container body is accommodated, it is possible to prevent the vent hole provided in the rear case from being blocked by the container body when the container body is accommodated.

  The liquid absorbing member may be in contact with the protruding portion.

  The tip of the protrusion comes into contact with the outer lid before peeling the outer lid of the container body when the container body is accommodated, and the inner lid of the container body after peeling the outer lid, so that the drug adheres when the drug droops. However, since the liquid-absorbing member abuts on the tip of the protrusion, the liquid-absorbing member can more reliably absorb the medicine.

  Further, the outer lid is configured to be peeled from the container body by pulling an extending portion extending from the outer lid, and the extending portion is provided in the casing when the container body is accommodated. The liquid-absorbing member may extend outward from the drawn outlet and extend from the gap toward the outlet.

  When the drug is accumulated between the outer lid and the inner lid, when the extension part is pulled and the outer lid is peeled off, the drug tends to flow toward the outlet of the extension part. Since it extends toward the said outlet from a clearance gap, a chemical | medical agent can be more reliably absorbed with a liquid absorptive member. At this time, the outer lid is peeled so that the inner side surface (the surface forming the interface with the inner lid) is opposed to the liquid-absorbing member. The inner surface comes into contact with the liquid-absorbing member. Therefore, even if the medicine is attached to the outer lid, the medicine on the outer lid can be further removed by the liquid absorbing member. Thereby, it can suppress that a chemical | medical agent remains on the outer lid taken out from the drawer outlet, and adheres to a user's hand, clothes, etc.

  Further, the liquid absorbing member may be provided so as to cover a part of the vent hole.

  According to the above configuration, since the liquid absorbing member covers a part of the vent hole, the liquid absorbing member is exposed to the surrounding environment through the vent hole. Thereby, the chemical | medical agent absorbed with the liquid absorbing member can be volatilized directly to the surrounding environment.

  Moreover, you may make it the said housing | casing equip the side in which the said vent hole was provided with the fixture to the blower outlet of an air conditioning equipment.

  According to the said structure, air can be efficiently taken in into the ventilation hole of a housing | casing from the blower outlet of an air conditioner, and the volatilization efficiency of a chemical | medical agent can be improved.

  ADVANTAGE OF THE INVENTION According to this invention, the volatilization container which suppresses dripping of a volatile chemical | medical agent can be provided.

It is a side view of the container body which can be accommodated in the volatilization container concerning embodiment of this invention. It is a front view of the container body, (A) shows the state before bending the extension part, (B) shows the state which bent the extension part. It is a side view of the volatilization container concerning this Embodiment. It is a perspective view of the volatilization container. It is a perspective view of the front case of the volatilization container. It is a perspective view of the rear case of the volatilization container. It is a front view of the rear case of the volatilization container. It is a schematic diagram which shows the state by which the liquid absorbing member was attached to the case of the volatilization container. It is a schematic diagram which shows the structure of the liquid absorptive member concerning a modification. It is a schematic diagram which shows the structure of the liquid absorptive member concerning a modification.

  Hereinafter, a volatilization container according to a preferred embodiment of the present invention will be described with reference to the accompanying drawings. In order to facilitate the understanding of the description, the same constituent elements in the drawings will be denoted by the same reference numerals as much as possible, and redundant description will be omitted.

(Container structure)
First, the container body 10 which can be accommodated in the volatilization container 1 concerning embodiment of this invention is demonstrated. As shown in FIGS. 1 and 2, the container body 10 includes a container body 12 having a substantially circular shape when viewed from the front, and an extending portion 14 extending from the container body 12 in one direction.

  As shown in FIG. 1, the container body 12 includes a cup 120, an inner lid 122, and an outer lid 124.

  The cup 120 is a cup-shaped container body having an opening 120 </ b> A on the upper surface, and accommodates the volatile medicine M therein. The cup 120 is made of, for example, a transparent resin such as polypropylene or polyethylene terephthalate so that the remaining amount of the stored volatile drug M can be visually observed from the outside. Further, the cup 120 may be provided with a sealing layer made of polyethylene or the like so that an inner lid 122 and an outer lid 124 described later can be thermocompression bonded. In addition, the volatile chemical | medical agent M is a liquid or a gel-like chemical | medical agent, For example, an insect repellent, a fragrance | flavor, a deodorant, a fungicide, etc. are used.

  The inner lid 122 is disposed so as to cover the entire surface of the opening 120A, and specifically, is fixed to a flange 120B formed on the outer peripheral edge of the opening 120A of the cup 120. The inner lid 122 is a drug permeable sheet. The inner lid 122 is composed of, for example, polypropylene, polyethylene, polymethylpentene, an ethylene-vinyl acetate copolymer, an ethylene-acrylic acid copolymer, an ethylene-α olefin copolymer, etc., alone or in combination, for example, , Having a thickness of 10 to 100 μm. The inner lid 122 prevents the liquid or gel-like medicine M from flowing out, while vaporizing the medicine M that has passed through the inner lid 122 on its surface.

  The outer lid 124 is detachably stacked on the inner lid 122 so as to cover the inner lid 122. The outer lid 124 is a drug-impermeable sheet in which polyethylene, polyethylene terephthalate, or the like is laminated on an aluminum sheet, for example, and does not allow the drug M to pass therethrough. Thereby, in a state where the outer lid 124 is stacked on the inner lid 122 (before the outer lid 124 is peeled), the medicine M that has passed through the inner lid 122 is prevented from being volatilized.

  The inner lid 122 and the outer lid 124 are joined to the flange 120B of the cup 120 by, for example, laminating the inner lid 122 and the outer lid 124 on the cup 120 and then thermocompression bonding the outer lid 124. The outer lid 124 can be peeled off from the container main body 12 by pulling the extending portion 14, but the inner lid 122 is fused to the flange 120 </ b> B and peeled off from the container main body 12 when the outer lid is peeled off. There is nothing. Note that the method of joining the inner lid 122 and the outer lid 124 to the flange 120B is not limited to this, and for example, an adhesive or the like may be used.

  As shown in FIG. 2A, the extending portion 14 extends from the container body 12 in one direction (upward in the figure), and a notch groove 140 extends between the extending portion 14 and the extending portion 14. It extends so as to cross the part 14. As shown in FIG. 2B, the extending part 14 is folded back onto the container main body 12 by bending the extending part 14 toward the container main body 12 at the cut groove 140. The extending portion 14 is set to be sufficiently longer than the container body 12, and the distal end 142 of the extending portion 14 protrudes from the container body 12 in the folded state. In this state, the outer lid 124 is peeled off from the container body 12 together with the extending portion 14 by pulling the tip 142 of the extending portion 14 in the direction opposite to the extending direction (downward in the drawing). .

(Configuration of volatilization container)
The volatilization container 1 is made of, for example, plastic. As shown in FIGS. 3 and 4, the front case 2, the rear case 3, the outlet 4, the opening / closing lid 5, the fixture 6, and the liquid absorbing member 7 (FIG. 8). Etc.). The volatilization container 1 accommodates the container body 10 (FIGS. 1 and 2) described above in a casing configured by fitting the front case 2 and the rear case 3 together. The volatilization container 1 is used by being attached to an air conditioner of a vehicle, for example.

  As shown in FIG. 5, the front case 2 is a substantially hemispherical hollow body and includes a storage chamber 20, an opening 22, an engagement protrusion 24, an engagement hole 26, a notch 28, and the like.

  The storage chamber 20 includes a support wall 200 and a support piece 202, and stores the container body 10 in a space surrounded by these. The support wall 200 is suspended so as to be along the side surface of the cup 120 of the container body 10 when the container body 10 is accommodated, and the support piece 202 is suspended so as to contact the outer edge of the flange 120B of the container body 10. It is installed. Thereby, the position of the container body 10 is regulated in the storage chamber 20. The support piece 202 also functions as an engagement protrusion that engages with an engagement hole 38 </ b> A of the rear case 3 to be described later when the support piece 202 is joined to the rear case 3.

  The opening 22 is an opening formed in a half-moon shape on the front surface of the front case 2. In the container body 10, the cup 120 of the container body 10 is arranged in the storage chamber 20 so as to face the opening 22. Therefore, when the container body 10 is accommodated, a part of the cup 120 of the container body 10 becomes visible from the outside through the opening 22. Since the cup 120 is transparent, the medicine M therein is also visible. Therefore, the remaining amount of the medicine M can be grasped in a state where the container body 10 is accommodated in the volatilization container 1.

  The engagement protrusion 24 and the engagement hole 26 engage with an engagement hole 38B and an engagement protrusion 36 of the rear case 3 described later, respectively. The notch 28 is a slit provided in a part of the outer peripheral edge of the front case 2 and defines the outlet 4 together with a notch 39 of the rear case 3 described later.

  As shown in FIGS. 6 and 7, the rear case 3 has a substantially disk shape, and includes an opening 30, a vent hole 32, protrusions 34A and 34B, an engagement protrusion 36, engagement holes 38A and 38B, a cutout 39, and the like. It has. 6 and 7 are views of the rear case 3 as viewed from the inner side surface (the surface that faces the front case 2 when joined to the front case 2 and defines the internal space of the housing). is there.

  The opening 30 is provided substantially at the center of the rear case 3, and the tip of the fixture 6 (see FIGS. 3 and 4) is inserted therethrough.

  A plurality of ventilation holes 32 (six in this embodiment) are arranged at substantially equal intervals on a substantially concentric circle, and function as volatilization holes for taking in air inside and releasing volatilization medicine to the outside.

  As shown in FIG. 6, the protrusions 34 </ b> A and 34 </ b> B protrude from the inner surface of the rear case 3 in the vertical direction (toward the accommodation chamber 20 of the front case 2), and are arranged on a substantially concentric circle at intervals. ing. The protruding portion 34A is disposed with one air hole 32 interposed therebetween, and the protruding portion 34B is disposed at a position symmetrical to each other with the opening 30 interposed therebetween. The protruding lengths of the protruding portions 34 </ b> A and 34 </ b> B are the same, and are dimensioned so that the respective tips contact the surface of the outer lid 124 of the container body 10 when the container body 10 is accommodated.

  Since the protrusions 34A and 34B come into contact with the outer lid 124 of the container body 10 when the container body 10 is accommodated, the movement of the container body 10 to the rear case 3 is restricted. Further, since a gap is formed between the rear case 3 and the container body 10 when the container body 10 is accommodated, the vent hole 32 can be suppressed from being blocked by the container body 10 when the container body 10 is accommodated. Moreover, it can also be suppressed that the front-end | tip of the fixture 6 penetrated by the opening 30 contacts the inner cover 122 or the outer cover 124 of the container body 10, and is damaged.

  As described above, the engagement protrusion 36 and the engagement holes 38A and 38B engage with the engagement hole 26, the support piece 202, and the engagement protrusion 24 of the front case 2 when joined to the front case 2, respectively. The notch 39 is a slit provided in a part of the peripheral wall of the rear case 3, and defines the outlet 4 together with the notch 28 of the front case 2.

  Returning to FIG. 3 and FIG. 4, the description will be continued. The outlet 4 is a wide opening provided in a part of the casing of the volatilization container 1 and is defined by the notch 28 of the front case 2 and the notch 39 of the rear case 3 as described above. The opening width of the outlet 4 is larger than the extension part 14 of the container body 10, and when the container body 10 is accommodated, the extension part 14 bent to the container body 12 side (see FIG. 2B). The tip extends from the outlet 4.

  The opening / closing lid 5 is a thin disk-like plate disposed on the outer surface of the rear case 3 and can be rotated with respect to the rear case 3. The opening / closing lid 5 is provided with an opening having the same shape as the vent hole 32 of the rear case 3, and the vent hole 32 is opened by rotating the opening / closing lid 5 clockwise with respect to the rear case 3, in the reverse direction. The vent hole 32 is closed by rotating in the direction. That is, the opening / closing lid 5 functions as an opening / closing lid for the vent hole 32 of the rear case 3.

  The fixture 6 is a clip attached to the outer surface of the rear case 3. Although not shown in the drawings, the tip of the fixture 6 has a bar shape with a circular cross section, and is detachably inserted into the opening 30 of the rear case 3. The fixture 6 can be attached to, for example, a wing of an air outlet of a vehicle air conditioner, and polyacetal, polyamide, etc. are used from the viewpoint of shape restoration after installation and creeping resistance from the viewpoint of preventing scratches on the installation target. It is desirable to use materials such as elastomers.

  As shown in FIG. 8, the liquid absorbing member 7 (liquid absorbing member) is a sheet attached to the inner surface of the rear case 3. The liquid-absorbing member 7 is formed of a liquid-absorbing material such as, for example, paper, nonwoven fabric, felt-like woven fabric, and inorganic fiber, and can absorb the liquid medicine M leaking from the container body 10. Further, the liquid absorbing member 7 may contain liquid absorbing particles such as cyclodextrin. In this case, the leaked liquid drug M is supported on cyclodextrin or the like, and the drug M can be absorbed more efficiently.

  More specifically, the liquid absorbing member 7 has an elliptical shape and extends from the center of the rear case 3 toward the notch 39 (the outlet 4) while covering one of the vent holes 32. The liquid absorbing member 7 is disposed so as to face the storage chamber 20. When the liquid absorbing member 7 is stored in the container body 10 in the storage chamber 20, the liquid absorbing member 7 is attached to the inner lid 124 and the rear case 3. Located in the gap between the sides. The thickness of the liquid absorbing member 7 is determined according to the protruding lengths of the protrusions 34A and 34B, and the liquid absorbing member 7 contacts the surface of the outer lid 124 of the container body 10 when the container body 10 is accommodated. It is dimensioned to be in the vicinity.

(How to use the volatilization container)
Next, the usage method of the volatilization container 1 which accommodated the container body 10 is demonstrated. In the state in which the container body 10 is accommodated, the tip of the extended portion 14 (see FIG. 2B) of the container body 10 in the bent state extends from the outlet 4. When the user pulls the tip of the extending portion 14 in the extending direction, the container main body 12 itself is held in its position by the support wall 200, and the outer lid 124 is pulled together with the extending portion 14 to hold the container main body. 12 is peeled off and taken out from the outlet 4.

  Here, the interface between the inner lid 122 and the outer lid 124 of the container body 10 is in close contact with each other, and there is usually no gap between the two before the outer lid 124 is peeled off.

However, as a result of a large amount of medicine M permeating through the inner lid 122 before the outer lid 124 is peeled off, the bonding force at the interface between the inner lid 122 and the outer lid 124 is weakened, and a gap is formed. May accumulate as a liquid. In this state, when the user pulls the extended portion 14 extending from the outlet 4 to peel off the outer lid 124, the liquid medicine M collected in the gap is transferred from the inner lid 122 or the outer lid 124 and droops from the container body 10. I will put it out. Although different from the present embodiment, for example, when the gap occurs due to poor adhesion between the inner lid and the outer lid at the time of manufacture, the inner lid 122 and the outer lid 124 may change over time or due to deformation of the container body 12 or the like. When the adhesion is weakened and the adhesive between the inner lid 122 and the outer lid 124 is weakened due to the drug M impregnated in the inner lid 122, a gap is formed between the inner lid 122 and the outer lid 124 from the beginning by design. There may be a case where it is provided.
When there is such a gap, the medicine M that has volatilized and permeated through the inner lid 122 may be liquefied and accumulated in the gap between the inner lid 122 and the outer lid 124.

  Further, even after the outer lid 124 is peeled off, the medicine M may ooze out as a liquid on the inner lid 122 as a result of the volume of the container body 10 being reduced due to a high temperature environment or impact. Even in such a state, before the exuded medicine M volatilizes, it may travel down the inner lid 122 and droop out of the container body 10.

  However, in the present embodiment, the liquid absorbing member 7 is in contact with or located in the vicinity of the outer lid 124 at the time of peeling, and the inner lid 122 after the outer lid 124 is peeled off. The dropped liquid medicine M adheres to the liquid absorbing member 7 directly or dropwise. Since the liquid absorbing member 7 is made of a liquid absorbing material, the liquid absorbing member 7 absorbs the liquid medicine M dripping from the container body 10. Thereby, it can suppress that the chemical | medical agent M leaks out of the housing | casing of the volatilization container 1. FIG.

  In particular, the liquid medicine M easily moves toward the outlet 4 of the extending portion as the outer lid 124 is peeled off. However, since the liquid absorbing member 7 extends toward the outlet 4, the liquid medicine M M can be absorbed more reliably. Further, the outer lid 124 is peeled so that the inner side surface (the surface forming the interface with the inner lid 122) faces the liquid absorbing member 7, so that the outer lid 124 is removed from the pulling outlet until it is removed. This inner surface comes into contact with the liquid absorbing member 7. Therefore, even when the medicine M is attached to the outer lid 124, the medicine M on the outer lid 124 can be further removed by the liquid absorbing member 7. Thereby, it can suppress that a user's hand, clothes, etc. get dirty by the medicine remaining in the outer lid 124 taken out from the outlet 4.

  When the user peels the outer lid 124, the vaporized medicine M is released into the casing of the volatilization container 1 through the medicine-permeable inner lid 122. The user rotates the opening / closing lid 5 clockwise to expose the vent hole 32. Thereby, the medicine M released into the casing is mixed with the external air and volatilized in the surrounding environment. A user may attach the volatilization container 1 to the wing | blade of the blower outlet of the vehicle air conditioner using the clip of the fixture 6, for example. At this time, since the fixture 6 is provided on the outer surface of the case 3 after the ventilation hole 32 is provided, the ventilation hole 32 faces the air outlet of the air conditioner. Therefore, the air blown out from the air conditioner flows into the volatilization container 1 as it is, and the air can be efficiently taken into the housing.

  When the liquid absorbing member 7 absorbs the liquid medicine M, the medicine M is also gradually volatilized from the liquid absorbing member 7. Therefore, the medicine M can be used without waste. Moreover, since the liquid absorbing member 7 has a sheet shape and the absorbed medicine spreads in the surface direction, the absorbed medicine M can be efficiently volatilized in the surrounding environment. Furthermore, since the liquid absorbing member 7 covers one vent hole 32, it is exposed to the outside through the vent hole 32, so that the absorbed medicine M can be directly volatilized in the surrounding environment.

(Modification)
Although the embodiments of the present invention have been described above, the present invention is not limited to these embodiments, and can be implemented in various modes without departing from the scope of the present invention.

  For example, in the above embodiment, the liquid absorbing member 7 has an elliptical shape, but is not limited to this, and for example, a shape as shown in FIGS. 9 and 10 is possible.

  As shown in FIG. 9, the liquid absorbing member 8 according to the first modified example includes a circular portion 80 disposed substantially at the center of the rear case 3 and a pair of supports extending from the circular portion 80 in directions opposite to each other. Part 82. The support portion 82 has a substantially rectangular shape, and the tip is placed on the upper end of the protruding portion 34B.

  The protruding portion 34B contacts the outer lid 124 before the outer lid 124 of the container body 10 is peeled when the container body 10 is accommodated, and the inner lid 122 of the container body after the outer lid 124 is peeled off. Therefore, when the liquid medicine M leaks out, the liquid medicine M is easily transmitted to the protruding portion 34B. In the present modification, the support portion 82 of the liquid absorbing member 8 contacts the tip of the protrusion 34B, so that the liquid medicine M attached to the protrusion 34B can be absorbed by the support portion 82. Further, since the tip of the support portion 82 is placed on the upper end of the protruding portion 34B, even if the liquid absorbing member 8 is detached from the rear case 3 (for example, due to weak adhesion between them), The liquid member 8 can be supported by the protrusion 34B. In addition, since the liquid absorbing member 8 does not block the vent hole 32, the amount of air flowing into the housing can be increased as compared with a case where a part of the vent hole 32 is blocked.

  As shown in FIG. 10, the liquid absorbing member 9 according to the second modified example includes a circular portion 90 disposed substantially at the center of the rear case 3 and six support portions 92 extending radially from the circular portion 90. Has been. Each of the six support portions 92 has a substantially trapezoidal shape and extends between the vent holes 32, 32. Of the two support portions 92, the tips of the two support portions 92 abut against the protrusion 34 A and the other two support portions 92. The tip of the support portion 92 abuts on the protruding portion 34B. Thereby, the liquid absorption member 9 is clamped by the protrusions 34A and 34B.

  The protrusions 34 </ b> A and 34 </ b> B contact the outer lid 124 before the outer lid 124 of the container body 10 is peeled when the container body 10 is accommodated, and the inner lid 122 of the container body after the outer lid 124 is peeled off. Therefore, when the liquid medicine M drips, the liquid medicine M is easily transmitted to the protrusions 34A and 34B. In the present modification, the support portion 92 of the liquid absorbing member 9 comes into contact with the tips of the protrusions 34A and 34B, so that the liquid medicine M attached to the protrusions 34A and 34B can be absorbed by the support portion 92. Further, since the support portion 92 is sandwiched between the projecting portions 34A and 34, even when the liquid absorbing member 9 is detached from the rear case 3 (for example, due to weak adhesion between them), the liquid absorbing member 9 Can be supported by the protrusions 34A and 34B. Further, since the liquid absorbing member 9 does not block the vent hole 32, the amount of air flowing into the housing can be increased as compared with the case where a part of the vent hole 32 is blocked. In addition, since the support portions 92 are provided between the vent holes 32, the surface area of the entire liquid-absorbing member 9 is increased, and more liquid medicine M can be absorbed.

DESCRIPTION OF SYMBOLS 1 ... Volatilization container, 2 ... Front case, 20 ... Storage chamber, 200 ... Support wall, 202 ... Support piece, 22 ... Opening part, 24 ... Engagement protrusion, 26 ... Engagement hole, 28 …… Notch, 3 …… Rear case, 30 …… Open, 32 …… Vent hole, 34A, 34B …… Protrusion, 36 …… Engagement protrusion,
38A, 38B ... engagement hole, 39 ... notch, 4 ... outlet, 5 ... open / close lid, 6 ... fixture, 7, 8, 9 ... liquid absorbing member, 80, 90 ... circular part , 82, 92 ...... Supporting part, 10 ...... Container body, 12 ...... Container body, 120 ...... Cup, 120 A ...... Opening, 120 B ...... Flange, 122 ...... Inner lid, 124 ...... Outer lid, 14 ...... … Extension part, 140 …… groove, 142 …… tip

Claims (7)

It is a volatilization container that can accommodate a container body containing a volatile drug in the housing,
The container body includes an opening, a drug-permeable inner lid that covers the opening and is fixed to the container body, and a drug-impermeable outer lid that covers the inner lid and is detachably bonded to the container body. Have
The housing includes a vent hole, a storage chamber for storing the container body, and a liquid-absorbing member that contacts the outer lid when the container body is stored or is positioned in the vicinity of the outer lid. Volatilization container provided.   The volatilization container according to claim 1, wherein the liquid absorbing member is a sheet-like paper or a nonwoven fabric. The housing is configured by fitting a front case having the accommodation chamber and a rear case having the vent hole,
The rear case protrudes from the inner side surface of the rear case toward the storage chamber, and a tip of the rear case comes into contact with an outer lid of the container body when the container body is accommodated, so that the container body and the rear case are interposed. A protrusion defining a gap;
The volatilization container according to claim 1, wherein the liquid absorbing member is disposed in the gap.   The volatilization container according to claim 3, wherein the liquid-absorbing member is in contact with the protruding portion. The outer lid is configured to be peeled from the container body by pulling an extending portion extending from the outer lid, and the extending portion is provided in the housing when the container body is accommodated. Extending outside from the outlet,
The volatilization container according to claim 3, wherein the liquid absorbing member extends from the gap toward the outlet.   The volatilization container according to any one of claims 3 to 5, wherein the liquid absorbing member is provided so as to cover a part of the vent hole.   The said housing | casing is a volatilization container as described in any one of Claims 1 thru | or 6 provided with the fixture to the blower outlet of an air conditioner in the side in which the said vent hole was provided.

Images